Literature DB >> 35780182

Alkalization of cellular pH leads to cancer cell death by disrupting autophagy and mitochondrial function.

Chang Ying1, Chengmeng Jin1, Siying Zeng1, Ming Chao2, Xun Hu3.   

Abstract

We previously found that lactic acidosis in the tumor environment was permissive to cancer cell surviving under glucose deprivation and demonstrated that neutralizing lactic acidosis restored cancer cell susceptibility to glucose deprivation. We then reported that alternate infusion of bicarbonate and anticancer agent into tumors via tumor feeding artery markedly enhanced the efficacy of transarterial chemoembolization (TACE) in the local control of hepatocellular carcinoma (HCC). Here we sought to further investigate the mechanism by which bicarbonate enhances the anticancer activity of TACE. We propose that interfering cellular pH by bicarbonate could induce a cascade of molecular events leading to cancer cell death. Alkalizing cellular pH by bicarbonate decreased pH gradient (ΔpH), membrane potential (ΔΨm), and proton motive force (Δp) across the inner membrane of mitochondria; disruption of oxidative phosphorylation (OXPHOS) due to collapsed Δp led to a significant increase in adenosine monophosphate (AMP), which activated the classical AMPK-mediated autophagy. Meanwhile, the autophagic flux was ultimately blocked by increased cellular pH, reduced OXPHOS, and inhibition of lysosomal proton pump in alkalized lysosome. Bicarbonate also induced persistent mitochondrial permeability (MPT) and damaged mitochondria. Collectively, this study reveals that interfering cellular pH may provide a valuable approach to treat cancer.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35780182     DOI: 10.1038/s41388-022-02396-6

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  52 in total

Review 1.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 2.  Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Authors:  J-L Raoul; B Sangro; A Forner; V Mazzaferro; F Piscaglia; L Bolondi; R Lencioni
Journal:  Cancer Treat Rev       Date:  2010-08-17       Impact factor: 12.111

Review 3.  Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.

Authors:  M C Jansen; R van Hillegersberg; R A F M Chamuleau; O M van Delden; D J Gouma; T M van Gulik
Journal:  Eur J Surg Oncol       Date:  2005-05       Impact factor: 4.424

4.  The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

Authors:  Fabio Piscaglia; Luigi Bolondi
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

5.  Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation.

Authors:  Xun Hu; Ming Chao; Hao Wu
Journal:  Signal Transduct Target Ther       Date:  2017-03-10

6.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

Authors:  Josep M Llovet; Maria Isabel Real; Xavier Montaña; Ramon Planas; Susana Coll; John Aponte; Carmen Ayuso; Margarita Sala; Jordi Muchart; Ricard Solà; Joan Rodés; Jordi Bruix
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

7.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 8.  Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.

Authors:  Riccardo Lencioni; Thierry de Baere; Michael C Soulen; William S Rilling; Jean-Francois H Geschwind
Journal:  Hepatology       Date:  2016-03-07       Impact factor: 17.425

Review 9.  Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.

Authors:  Fabio Piscaglia; Sadahisa Ogasawara
Journal:  Liver Cancer       Date:  2018-01-12       Impact factor: 11.740

10.  Beyond Warburg effect--dual metabolic nature of cancer cells.

Authors:  Jiansheng Xie; Hao Wu; Chunyan Dai; Qiangrong Pan; Zonghui Ding; Danqing Hu; Bingyan Ji; Yan Luo; Xun Hu
Journal:  Sci Rep       Date:  2014-05-13       Impact factor: 4.379

View more
  1 in total

1.  c-Myc-Regulated lncRNA-IGFBP4 Suppresses Autophagy in Cervical Cancer-Originated HeLa Cells.

Authors:  Lei Zhang; Zongshan Zhang; Erwei Li; Poshi Xu
Journal:  Dis Markers       Date:  2022-08-29       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.